4.7 Article

Highly sensitive detection of extracellular vesicles on ZnO nanorods integrated microarray chips with cascade signal amplification and portable glucometer readout

期刊

SENSORS AND ACTUATORS B-CHEMICAL
卷 375, 期 -, 页码 -

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2022.132878

关键词

ZnO-chip; Extracellular vesicles; Cancer diagnosis; Signal amplification; Portable glucometer; Capture and release

向作者/读者索取更多资源

Researchers have developed a ZnO nanorods integrated microarray chip (ZnO-chip) for effective capture and sensitive detection of extracellular vesicles (EVs), which have potential as biomarkers for cancer diagnosis in liquid biopsy. The chip provides abundant binding sites for EVs capture and utilizes cascade signal amplification for accurate quantitation. The method has the ability to distinguish cancer patients from healthy individuals and could be applied for routine screening in clinical trials.
Extracellular vesicle (EV) has become a type of potential biomarker for cancer diagnosis in liquid biopsy. However, the accurate detection of EVs for large-scale cancer scanning is still challenge due to the low sensi-tivity, high cost, and requirement of large instruments, which impedes their wide applications in clinical trials, especially in resource limited areas. Herein, we report a ZnO nanorods integrated microarray chip (ZnO-chip) for effective capture and sensitive detection of EVs. The ZnO-chip provides abundant binding sites for EVs capture. Meanwhile, the high-ordered hybridization chain reaction and non-ordered enzyme catalytic reaction are collaborated for cascade signal amplification. The oxidized product, glucose, can be read out directly by portable glucometer to realize accurate quantitation of EVs with a linear range of 1.0 x 104 to 8.4 x 107 particles/mu L and a minimal detectable concentration of 3.3 x 103 particles/mu L. Our approach could distinguish cancer patients from healthy individuals, proving the statistically increase of EVs in serums of cancer patients. Finally, we verify that the captured EVs can be released for downstream molecular assays by dissolving ZnO nanorods under slightly acidic condition. We believe our approach has remarkable possibility for the routine screening of cancer patients in clinical trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据